Literature DB >> 17019654

Implementation of MR colonography.

M P Achiam1, E Chabanova, V Løgager, H S Thomsen, J Rosenberg.   

Abstract

BACKGROUND: MR colonography (MRC) is a promising method of examining the colon, but is limited to a few specialist centres. The purpose of this article was to describe the implementation of MRC with fecal tagging.
MATERIALS AND METHODS: Patients referred for conventional colonoscopy (CC) were offered MRC with fecal tagging before CC. Two days before MRC patients ingested an oral contrast agent. Before and after MRC and CC a number of questions were addressed. MR images were rated by a blinded investigator.
RESULTS: In 6 months, 30 consecutive patients were included. The median time in the MR suite was 44 min, 23 min for the MRC examination and 9 min for the evaluation. The median time for CC was 32 min. Sixty-six percent of the patients preferred MRC as the future method of examination, 10% preferred CC, 21% had no preferences. Of the oral contrast agents, barium sulphate with ferumoxsil was significantly better than barium sulphate alone.
CONCLUSION: The majority of the patients found MRC less unpleasant than CC and a majority would prefer MRC over CC as a future colon examination. MRC also appears to be less time consuming to the patients and medical personnel than CC with post-procedural monitoring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17019654     DOI: 10.1007/s00261-006-9143-7

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  2 in total

1.  Magnetic air capsule robotic system: proof of concept of a novel approach for painless colonoscopy.

Authors:  P Valdastri; G Ciuti; A Verbeni; A Menciassi; P Dario; A Arezzo; M Morino
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

2.  Patient experiences of MR colonography and colonoscopy: a qualitative study.

Authors:  R Hafeez; C V Wagner; S Smith; P Boulos; S Halligan; S Bloom; S A Taylor
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.